ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Sunday, 8 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Adverse Business Impact

Brooks Laboratories Adverse Business Impact

Brooks Laboratories announced its associate entity decided to terminate the proposed composite scheme of arrangement. The transaction will not be pursued in its current form.

Source

BSE filing, NSE: BROOKS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Brooks Laboratories Ltd: key numbers

Share price
₹63.25
Market cap
₹186.3 Cr
Revenue (annual)
₹85.74 Cr
Net profit (annual)
₹24.58 Cr
P/E (TTM)
14.1×Sector 43.0×
Promoter holding
52.62%+0.00% QoQ
FII holding
0.04%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Brooks Laboratories Ltd

All →

Other adverse business impact announcements

All →